MPLT
Financials
- Market Capitalization 1.71 B
- Employee 133
- Founded 2018
- CEO N/A
- Website www.maplightrx.com
- Headquarter Delaware, United States
- FIGI BBG01JZ5DBQ0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2084 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.34 USD | +1.21% | -15.01% | +1.21% | -37.10% | 1.77 B USD | ||
| 2112 |  FTRE Fortrea Holdings Inc. - Common Stock | 18.07 USD | +1.18% | +4.39% | +8.14% | +255.01% | 1.71 B USD | ||
| 2114 |  IMCR Immunocore Holdings plc - American Depositary Shares | 33.50 USD | +3.11% | +3.75% | +15.68% | +0.06% | 1.70 B USD | ||
| 2123 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 6.52 USD | +2.52% | +11.07% | +29.88% | +145.11% | 1.68 B USD |
Frequently asked questions about MapLight Therapeutics, Inc. - Common Stock
What is the MapLight Therapeutics, Inc. - Common Stock stock price today?
The current price of MapLight Therapeutics, Inc. - Common Stock (MPLT) is 37.62. Over the past 24 hours, the stock has changed by +2.87%. Follow the MPLT chart for real-time price dynamics.
What is the stock ticker of MapLight Therapeutics, Inc. - Common Stock?
MapLight Therapeutics, Inc. - Common Stock trades under the ticker MPLT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is MapLight Therapeutics, Inc. - Common Stock stock going up?
MPLT has changed by +1.24% over the last week, +34.89% over the last month, and +98.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was MapLight Therapeutics, Inc. - Common Stock net income for the last quarter?
MapLight Therapeutics, Inc. - Common Stock reported net income of -60.67 M for the last quarter. The previous quarter showed -79.55 M, which means net income changed by +23.73%.
How many employees does MapLight Therapeutics, Inc. - Common Stock have?
As of the latest available data, MapLight Therapeutics, Inc. - Common Stock has 133 employees. Workforce size can provide additional context about the company's scale and operations.
What is MapLight Therapeutics, Inc. - Common Stock EBITDA?
MapLight Therapeutics, Inc. - Common Stock EBITDA is -65.16 M, and its EBITDA margin is 1.63 M%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy MapLight Therapeutics, Inc. - Common Stock stock?
You can buy MapLight Therapeutics, Inc. - Common Stock (MPLT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in MapLight Therapeutics, Inc. - Common Stock stock?
Investing in MapLight Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MPLT chart and related analysis on metatrader.com as part of your research.